Thalassaemia trials in Oman

1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Where

  Muscat

  Age

  2 years and over

  People

  480 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06609226 · EU 2024-510805-27-00